Construction and validation of the CRISPR/dCas9-EZH2 system for targeted H3K27Me3 modification
Construction and validation of the CRISPR/dCas9-EZH2 system for targeted H3K27Me3 modification
复制标题
用于靶向 H3K27Me3 修饰的 CRISPR/dCas9-EZH2 系统的构建和验证
DOI:
10.1016/j.bbrc.2019.02.011
复制
发表时间:
2019-04-02
影响因子:
3.1
通讯作者:
Song, Yingliang
中科院分区:
文献类型:
--
作者:
Chen, Xutao;Wei, Mengying;Song, Yingliang
Cell phenotypes are closely related to the epigenome, which could be precisely regulated by the targeted manipulation of epigenetic marks. Here, we have successfully produced a targeted histone methylation system, which consists of nuclease-null dCas9 protein, the sgRNA fused with PP7 RNA aptamers and the Enhancer of Zeste Homolog 2 (EZH2) fused to PP7 coat protein (PCP). Guided by the dCas9/sgRNA-PP7, the PCP-EZH2 can specifically target gene loci to catalyze 3 methylation of histone H3 lysine 27, resulting in the inhibition of gene expression. This kind of gene inhibition system is supposed to be highly effective, specific and flexible. As a proof-of-concept study, sgRNA targeting C/ebp alpha promoter region was designed. In the cells co-infected with the dCas9, sgRNA/C/ebp alpha-PP7 and PCP-EZH2, the expression of C/ebp alpha gene was significantly reduced via induction of trimethylation to H3K27 on C/ebp alpha promoter, with the results epigenetically inherited in the daughter cells. In conclusion, our results successfully established a gene modification system consisting of dCas9/sgRNA-PP7 and PCP-EZH2, providing a robust tool for targeted manipulation of gene epigenetic modification and expression. (C) 2019 Published by Elsevier Inc.